Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in the literature. We present a case of a 71-year-old male with a rapidly growing retro-areolar mass. The histopathological and immunohistochemical evaluation confirmed a diagnosis of primary neuroendocrine carcinoma of the breast, with positivity for chromogranin A, synaptophysin, and CD56 and a Ki-67 proliferative index of 30%. The patient underwent total mastectomy with axillary lymph node dissection followed by adjuvant tamoxifen. At 24-month follow-up, he remains disease-free. This case highlights the diagnostic challenges of male neuroendocrine breast carcinoma (NEBC) and emphasizes the critical role of histopathology and immunohistochemistry in achieving an accurate diagnosis. We provide a comprehensive review of the literature, propose a management algorithm, and suggest future research directions to address knowledge gaps in this rare malignancy. This report adheres to the SCARE 2020 criteria for surgical case reports.
No takes yet. Share an insight, caveat, or question.
Benbenaissa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: